Putnam Investments LLC Aerie Pharmaceuticals Inc Transaction History

Putnam Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$18.41 - $28.0 $1.14 Million - $1.74 Million	-62,113 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $241,088 - $401,203	8,322 Added 15.47%	62,113 $1.84 Million
Q1 2019 May 15, 2019	BUY	$36.32 - $49.25 $292,121 - $396,117	8,043 Added 17.58%	53,791 $2.56 Million
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $1.64 Million - $2.16 Million	29,231 Added 176.98%	45,748 $2.82 Million
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $790,338 - $1.16 Million	16,517 New	16,517 $1.12 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.